Novel antitumor strategies by targeting to eicosanoid receptor-mediated cellular signaling
Novel antitumor strategies by targeting to eicosanoid receptor-mediated cellular signaling
批准号:
22700920
负责人:
TAKAHASHI Tetsuyuki
金额:
$2.58万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Young Scientists (B)
财政年份:
2010
资助国家:
日本
项目状态:
已结题
起止时间:
2010 至 2011
关键词:
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The soluble prostaglandin E_2 receptor(FuEP2/ Ex2) suppressed cancer cell growth and production of hemorrhagic ascites in an orthotopic xenograft model of endometrial cancer and intraperitoneal dissemination model of ovarian cancer. In endometrial cancer, we also revealed that this inhibition was associated with suppression of ERK1/ 2-phosphorylation and COX-2, VEGF, and c-fos mRNA induction, which are consequences of EP receptor-elicited cellular signaling. By using conditional expression system which can be controlled by doxycycline, we obtained stable transfectant of 15-hydroxyprostaglandin dehydrogenase(15-PGDH) derived from human pancreas cancer cell line. We found that expression of 15-PGDH causes decrease of cell growth and survival rate, desensitization to insulin-and epidermal growth factor-induced cell growth, and sensitization to TNF-related apoptosis inducing ligand-induced apoptosis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
15-PGDH influences cell growth and susceptibility to apoptotic induction in pancreas cancer cells
15-PGDH 影响胰腺癌细胞的细胞生长和凋亡诱导的易感性
DOI:
--
发表时间:
2011
期刊:
影响因子:
--
作者:
[Iwanaga K, Sueoka-Aragane N, Sato A, Nakamura T, Kobayashi N, Sueoka E, Kimura S., 塚原智典, 高橋徹行]
通讯作者:
高橋徹行
A novel signaling crosstalk between prostaglandin E2 receptors and IGF-1 receptor as a possible molecular target for antitumor therapy
-
批准号:15K06873
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.24万
-
财政年份:2015
-
负责人:TAKAHASHI Tetsuyuki
-
依托单位:
Utility of arachidonic acid metabolism-related molecules as a novel target to anti-tumor strategy
-
批准号:24701026
-
项目类别:Grant-in-Aid for Young Scientists (B)
-
资助金额:$2.83万
-
财政年份:2012
-
负责人:TAKAHASHI Tetsuyuki
-
依托单位:
海外基金